Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Mahavadi, M. Korfei, I. Henneke, W. Seeger, A. Guenther, C. Ruppert (Giessen, Hessen, Germany). Evidence of type II pneumocyte apoptosis in the murine model of Hermansky-Pudlak-syndrome associated interstitial pneumonia. Eur Respir J 2008; 32: Suppl. 52, 728

Member's Comments

No comment yet.

Related content which might interest you: The role of cell lines in modelling the type II pneumocyte in interstitial lung disease Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease Year: 2020 Aging causes alveolar epithelial type II cell dysfunction in acute lung injury Source: ERS Lung Science Conference 2020 Year: 2020 Type II pneumocyte transplantation in ARDS Source: International Congress 2016 – Cell therapy for ARDS and sepsis Year: 2016 The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004 The effect of tenascin-c deficiency on TGF-β-mediated fibrosis and alveolar inflammation in a murine model of ARDS Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes Source: Eur Respir Mon; 2009: 46: 47–66 Year: 2009 Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Late Breaking Abstract - Aging impairs alveolar epithelial type II cell function in acute lung injury Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology Year: 2019 Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Source: Eur Respir J 2007; 29: 1105-1114 Year: 2007 Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Chlamydia pneumoniae persists in TLR2 positive alveolar epithelial cells type II and alveolar macrophages of COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 350s Year: 2003 Imbalance of glutathione metabolism in type II pneumocytes after NO2 induced acute and chronic lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 108s Year: 2004 Hyperoxia reversibly inhibits the transdifferentiation of alveolar type II (ATII) cells to alveolar type I (ATI) cells Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation Source: ERJ Open Res, 5 (4) 00138-2019; 10.1183/23120541.00138-2019 Year: 2019 Effect of hypoxia on gene regulation and differentiation in alveolar epithelial type II cells Source: Eur Respir J 2001; 18: Suppl. 33, 162s Year: 2001 Proliferation of alveolar type II pneumocytes is stimulated by Jagged-1 in vitro Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19 Source: Eur Respir J, 57 (2) 2002737; 10.1183/13993003.02737-2020 Year: 2021 Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013